Autor/Autorin: Refaat Eman
Dr. Eman Refaat Youness, MD, Medical Biochemistry, Faculty of Medicine, Cairo university, Assistant professor of Medical Biochemistry, National Research centre, Egypt. Experienced in experimental design, clinical Researches, DNA, PCR, have a lot of international publications, member in international societies. Reviewer and editor in many journals.
Rheumatoid arthritis (RA) is classified as a chronic disorder, meaning the progression of symptoms worsens over time. Patients may experience a rapid progression of the debilitating effects. As the synovium lining wears away or becomes inflamed, discomfort and risk for bone damage increase. Mesenchymal stem cells are known for their strong immunosuppressive by producing soluble mediators such as anti-inflammatory cytokines and might be useful as a therapeutic application in autoimmune diseases.
Über den Autor
Dra. Eman Refaat Youness, doctora en Bioquímica Médica, Facultad de Medicina, Universidad de El Cairo, profesora adjunta de Bioquímica Médica, Centro Nacional de Investigación, Egipto, con experiencia en diseño experimental, investigaciones clínicas, numerosas publicaciones internacionales, miembro de sociedades internacionales, revisora y editora de numerosas revistas.
Klappentext
Rheumatoid arthritis (RA) is classified as a chronic disorder, meaning the progression of symptoms worsens over time. Patients may experience a rapid progression of the debilitating effects. As the synovium lining wears away or becomes inflamed, discomfort and risk for bone damage increase. Mesenchymal stem cells are known for their strong immunosuppressive by producing soluble mediators such as anti-inflammatory cytokines and might be useful as a therapeutic application in autoimmune diseases.
